http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5849189-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D69-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D71-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D69-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D69-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D69-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D71-16 |
| filingDate | 1995-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97e1824966747d20f55be5d9d5141ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfe1957047c0dbe8723467e462c6f5e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8a54edac9f24ae9abb3a19134f8eb1 |
| publicationDate | 1998-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5849189-A |
| titleOfInvention | Hollow fiber blood purifying membrane and process for its production |
| abstract | PCT No. PCT/JP95/00339 Sec. 371 Date Nov. 6, 1995 Sec. 102(e) Date Nov. 6, 1995 PCT Filed Mar. 2, 1995 PCT Pub. No. WO95/24262 PCT Pub. Date Sep. 14, 1995A hollow fiber blood purifying membrane which is a hollow fiber membrane substantially composed of cellulose acetate, has a substantially non-oriented distribution of cellulose acetate polymer particles on the inner surface of the hollow fibers, has a dense layer with a thickness in the range of 30-1000 nm on both the inner and outer surface of the hollow fibers and a porous structure which is substantially uniform at the membrane wall between the two dense layers, and has an in vitro ultrafiltration rate (UFR) of 10 to 50 ml/m2xmmHgxhr and a (in vivo UFR)/(in vitro UFR) ratio of at least 0.3, a blood plasma albumin permeation blockage of at least 90%, and an in vivo beta 2-microglobulin ( beta 2-MG) sieving coefficient of at least 0.4, as well as a process for its production. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7442302-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6013182-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006191844-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6372136-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6632366-B1 |
| priorityDate | 1994-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.